Skip to Content

In the News

Laboratory News

04/04/2013: Congratulations to Aaron Brown on receiving the MD Anderson Alumni and Faculty Association Trainee Excellence Award for presentations given during medical or scientific meetings of professional societies between the time periods of August1, 2012 – February 28, 2013.

03/31/2013: Congratulations to Kevin Kotamarti on receiving the Radiological Society of North America Research Medical Student Grant.

01/08/2013:  New book titled "Cancer Nanotechnology: Principles and Applications in Radiation Oncology" edited by Dr Krishnan and Dr Cho published. The link is here.

11/11/2012: Our lab welcomes Dr Pankaj Kumar Singh, who joins as a postdoctoral fellow from the Armed Forces Research Institute.

03/19/2012: Our lab welcomes Dr Shanta Raj Bhattarai, Ph.D., who joins as an Instructor. Dr Bhattarai has a PhD in bionanosystems engineering from Korea. Prior to joining our lab he was did a stints of postdoctoral research in pharmaceutical sciences at Wayne State University (MI), in bionanomaterials at Lawrence Berkeley National Lab, Berkeley; and in Bioengineering at CHORI, Oakland and UC Berkeley, CA.

01/30/2012: Our lab welcomes Tatiana Marques Pinto from the University of Sao Paulo where she worked within the Nanobiomedical Network and the Advanced Institute of Health in Ribeirão Preto. She came to joint our research group in order to develop part of her PhD thesis in Nanomedicine conjugated to Radiation Therapy, initiated at University of Sao Paulo in Brazil. This research is being supported either by NanoBioMed Network - CAPES Brazil and MDAnderson Cancer Center - Houston. As a Medical Physicist, she has knowledge in physics applied to medicine as radiation physics and dosimetry, MRI and radiology 

01/24/2012: Wishing all a prosperous Year of the Dragon!

01/01/2012: Wishing everybody a very happy and prosperous new year!

12/02/2011: New article published! “Intensity-Modulated Radiation Therapy with Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma.”  Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P. Int J Radiat Oncol Biol Phys. 2011 Dec 2. (Read the abstract)

11/01/2011: Congratulations to Dr. Amit Deorukhkar for promotion to Instructor!

10/02/2011: New article published! “Charged-particle therapy for hepatocellular carcinoma.” Skinner HD, Hong TS, Krishnan S. Semin Radiat Oncol. 2011 Oct, 21
(4):278-86. (Read the abstract)

In the Media

06/30/2008: Engineer receives $1.5M grant for nanoparticle cancer research

A biomedical engineering assistant professor at The University of Texas at Austin has been awarded a $1.5 million National Institutes of Health/National Cancer Institute grant to conduct nanoparticle cancer research. Grant recipient James Tunnell says the five-year project will include collaboration with other researchers from the university, MD Anderson Cancer Center in Houston and the University of California at Irvine. (Read more)

 

05/01/2008: Nanoparticle-Induced Heating Boosts Antitumor Radiation Therapy

Radiation therapy is a time-honored and effective component of modern cancer therapy, but its ultimate utility is limited by the fact that some cancer cells are resistant to ionizing radiation. Now, a research team led by Sunil Krishnan, M.D., of The University of Texas MD Anderson Cancer Center, has found that pretreating tumors with gold nanoparticles and near-infrared radiation dramatically improves the response of tumors to radiation therapy. (Read more)

 

02/15/2008: Fluorescent Nanoparticles Image Tumor Marker in Animals

Reporting its work in the journal Clinical Cancer Research, a team of investigators at the MD Anderson Cancer Center, led by Sunil Krishnan, M.D., and Juri Gelovani, M.D., Ph.D., describes its design of a near-infrared quantum dot linked to epidermal growth factor and used to image tumors that overexpress EGFR in a mouse model of human colon cancer. Binding assays showed that this construct was capable of recognizing and binding to EGFR with only a slight reduction in affinity compared with native epidermal growth factor. However, activity assays showed that the targeted quantum dot did not activate EGFR, which could cause complications for a potential imaging agent by triggering unwanted tumor cell growth. (Read more)


© 2014 The University of Texas MD Anderson Cancer Center